Albumin-bound composition including LRRD2 of slit3 protein for prevention or treatment of bone-related diseases
PH12021552079B1Active Publication Date: 2026-09-16DAEWOONG PHARM CO LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12021552079
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-08-27
- Publication Date
- 2026-09-16
- Estimated Expiration
- 2041-08-27
Abstract
The present invention relates to an albumin-bound composition including LRRD2 of SLIT3 protein for prevention or treatment of bone-related diseases.
Need to check novelty before this filing date? Find Prior Art